$15.50
-0.53-3.31%
近くで: Nov 20, 4:00 PM EST
$15.50
N/A
時間外: Nov 20, 4:00 PM EST

The average analyst price target for Dyne Therapeutics is $36.95, 138.4% above the current price. Of 17 analysts, 15 rate it Buy, 1 Hold and 1 Sell. Targets range from $10 to $56. The latest change came on Oct 28, 2026, when Oppenheimer downgraded Dyne Therapeutics from Outperform to Perform and moved its price target from $40 to $15.
Price Target Range — 12 Quarters
Analyst Consensus — 17 Analysts
Rating Trend — Last 9 Months